Mimetic Multimodal Peptide (Asclepix Therapeutics)

N/A

Report date: 2025/01/26 15:50:01

Base Information

Drug NameMimetic Multimodal Peptide (Asclepix Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsclepiX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAsclepiX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A